|
|
xiii | |
Series Preface |
|
xvii | |
Preface |
|
xix | |
|
1 Chronic Wound Healing: Molecular and Biochemical Basis |
|
|
1 | (20) |
|
|
|
|
1 | (1) |
|
|
1 | (2) |
|
1.3 Categories of Chronic Wound |
|
|
3 | (1) |
|
|
3 | (1) |
|
1.3.2 Venous Stasis Ulcers |
|
|
4 | (1) |
|
|
4 | (1) |
|
1.3.4 Diabetic Foot Ulcers |
|
|
4 | (1) |
|
1.4 How a Chronic Wound Develops: Intrinsic Components |
|
|
4 | (9) |
|
|
5 | (1) |
|
1.4.2 Immune Cells and Inflammatory Mediators |
|
|
6 | (2) |
|
1.4.3 Reactive Oxygen Species |
|
|
8 | (1) |
|
|
8 | (4) |
|
1.4.5 The Role of Matrix Metalloproteinases |
|
|
12 | (1) |
|
1.5 How a Chronic Wound Develops: Extrinsic Factors |
|
|
13 | (2) |
|
|
13 | (1) |
|
|
13 | (1) |
|
|
14 | (1) |
|
1.5.4 Hypoxia and Ischaemia-Reperfusion Injury |
|
|
15 | (1) |
|
|
15 | (6) |
|
|
16 | (5) |
|
2 Clinical Perspectives for Treating Chronic Wounds |
|
|
21 | (22) |
|
|
|
|
|
|
|
21 | (1) |
|
2.2 Aetiology of Diabetic Foot Ulcers |
|
|
22 | (1) |
|
2.3 Standard of Care for Treatment of Diabetic Foot Ulcers |
|
|
22 | (1) |
|
2.4 Commonly Used Wound Dressings for Diabetic Foot Ulcers and Their Mechanism of Action |
|
|
22 | (1) |
|
2.5 Absorbent and Superabsorbent Dressings |
|
|
23 | (1) |
|
|
23 | (1) |
|
|
23 | (1) |
|
|
24 | (1) |
|
|
24 | (1) |
|
|
25 | (1) |
|
2.11 The Role of a Split Thickness Skin Graft in Diabetic Foot Ulcers |
|
|
25 | (1) |
|
2.12 Negative Pressure Wound Therapy |
|
|
25 | (2) |
|
|
27 | (1) |
|
2.14 Clinical Case Studies from Multidisciplinary Diabetic Foot Clinic |
|
|
27 | (12) |
|
|
27 | (2) |
|
|
29 | (2) |
|
2.14.3 Neuro-Ischaemic Wound |
|
|
31 | (2) |
|
|
33 | (2) |
|
|
35 | (1) |
|
2.14.6 Necrotising Fasciitis in a Patient with Diabetes |
|
|
36 | (3) |
|
|
39 | (4) |
|
|
39 | (1) |
|
|
39 | (4) |
|
3 Prediction, Prevention, Assessment, and Management of Skin Tears in the Aging Population |
|
|
43 | (16) |
|
|
|
|
43 | (1) |
|
3.2 Skin Tear Prevalence and Incidence |
|
|
44 | (1) |
|
3.3 Predicting Skin Tears |
|
|
45 | (2) |
|
|
47 | (2) |
|
3.5 ISTAP Risk Reduction Program |
|
|
49 | (3) |
|
|
49 | (1) |
|
|
50 | (1) |
|
|
51 | (1) |
|
|
52 | (2) |
|
|
54 | (1) |
|
|
54 | (1) |
|
|
55 | (4) |
|
|
55 | (4) |
|
4 Importance of Debriding and Wound Cleansing Agents in Wound Healing |
|
|
59 | (32) |
|
|
|
|
|
|
|
|
59 | (1) |
|
4.2 The History of Debridement |
|
|
59 | (1) |
|
4.3 Why Undertake Debridement? |
|
|
60 | (2) |
|
4.4 Debridement Techniques and Wound Cleansing Agents |
|
|
62 | (19) |
|
4.4.1 Mechanical Debridement |
|
|
62 | (10) |
|
4.4.2 Biological Debridement |
|
|
72 | (2) |
|
4.4.3 Enzymatic Debridement |
|
|
74 | (3) |
|
4.4.4 Autolytic Debridement |
|
|
77 | (2) |
|
|
79 | (1) |
|
4.4.6 Other Debridement Therapies |
|
|
80 | (1) |
|
4.5 What is the Future of Debridement? |
|
|
81 | (10) |
|
|
82 | (9) |
|
5 Treatment of Mixed Infections in Wounds |
|
|
91 | (24) |
|
|
|
|
91 | (3) |
|
5.1.1 Wound Healing Process |
|
|
92 | (1) |
|
5.1.2 Types of Chronic Wounds |
|
|
92 | (2) |
|
5.2 Prevalence of Mixed Infections |
|
|
94 | (6) |
|
5.2.1 Bacterial-Fungal Interactions |
|
|
95 | (3) |
|
5.2.2 Bacterial-Bacterial Interactions |
|
|
98 | (1) |
|
5.2.3 Host Responses to Mixed Infections and Drug Resistance |
|
|
99 | (1) |
|
5.3 Management of Mixed Infected Wounds |
|
|
100 | (4) |
|
5.3.1 Clinical and Microbiological Diagnosis |
|
|
101 | (1) |
|
5.3.2 Debridement and Cleansing |
|
|
101 | (1) |
|
5.3.3 Antimicrobial Therapies |
|
|
102 | (2) |
|
5.3.4 Hyperbaric Oxygen Therapy |
|
|
104 | (1) |
|
|
104 | (1) |
|
5.4 Summary and Future Perspectives |
|
|
104 | (11) |
|
|
105 | (10) |
|
6 Treatment of Biofilms in Infected Wounds |
|
|
115 | (22) |
|
|
|
|
|
115 | (1) |
|
6.2 Why and How Biofilms Form |
|
|
116 | (2) |
|
|
118 | (1) |
|
|
119 | (1) |
|
|
119 | (7) |
|
6.4.1 Simulation of Biofilms in Wounds |
|
|
120 | (6) |
|
6.5 Treatment of Biofilms in Wounds |
|
|
126 | (2) |
|
6.5.1 Biofilm Eradication |
|
|
126 | (2) |
|
6.5.2 Current Treatment Protocols |
|
|
128 | (1) |
|
|
128 | (1) |
|
|
128 | (9) |
|
|
130 | (7) |
|
7 Freeze-Dried Wafers for Wound Healing |
|
|
137 | (20) |
|
|
|
137 | (1) |
|
7.2 Wafer as a Modern Wound Dressing |
|
|
138 | (1) |
|
7.3 Freeze-Drying Process |
|
|
139 | (1) |
|
|
140 | (1) |
|
|
141 | (5) |
|
|
142 | (2) |
|
|
144 | (1) |
|
7.5.3 Mechanical Properties |
|
|
145 | (1) |
|
7.5.4 In Vitro Drug Release |
|
|
145 | (1) |
|
|
146 | (1) |
|
|
146 | (4) |
|
|
147 | (1) |
|
|
148 | (1) |
|
7.6.3 Carboxymethylcellulose |
|
|
149 | (1) |
|
|
150 | (7) |
|
|
150 | (7) |
|
8 Silver and Silver Nanoparticle-Based Antimicrobial Dressings |
|
|
157 | (28) |
|
|
|
|
157 | (10) |
|
8.1.1 Brief History of Silver as an Antibiotic |
|
|
159 | (1) |
|
8.1.2 Mechanism of Action |
|
|
160 | (4) |
|
8.1.3 Bacterial Resistance to Silver |
|
|
164 | (3) |
|
8.2 Silver Dressings in Wound Healing |
|
|
167 | (8) |
|
8.2.1 Silver-Based Antimicrobial Dressings |
|
|
169 | (1) |
|
8.2.2 Silver Nanoparticle-Based Antimicrobial Dressings |
|
|
170 | (5) |
|
8.3 Cost-Effectiveness of Silver Dressings |
|
|
175 | (1) |
|
|
176 | (9) |
|
|
177 | (8) |
|
|
185 | (24) |
|
|
|
|
|
185 | (2) |
|
9.1.1 Classification by Origin of Materials Used to Prepare Hydrogels |
|
|
186 | (1) |
|
9.1.2 Classification by Composition and Structure of Hydrogels |
|
|
186 | (1) |
|
9.1.3 Classification by the Type of Cross-Linking |
|
|
187 | (1) |
|
9.1.4 Classification Based on the Shape and Dimensions of Hydrogels |
|
|
187 | (1) |
|
9.1.5 Classification Based on the Charge of Macromolecules Forming Hydrogels |
|
|
187 | (1) |
|
9.1.6 Classification Based on Functional Properties of the Hydrogels |
|
|
187 | (1) |
|
9.2 Mechanism of Hydrogel Swelling |
|
|
187 | (4) |
|
9.2.1 Swelling of Temperature-Sensitive Hydrogels and Their Application in Wound Healing |
|
|
189 | (1) |
|
9.2.2 Swelling of Light-Sensitive Hydrogels |
|
|
190 | (1) |
|
9.2.3 Swelling of Electro-Sensitive Hydrogels |
|
|
191 | (1) |
|
9.3 Application of Hydrogels as Wound Dressings |
|
|
191 | (2) |
|
9.4 Industrial Methods for the Synthesis of Hydrogels for Wound Dressings |
|
|
193 | (5) |
|
9.4.1 Polymerization Methods |
|
|
193 | (2) |
|
9.4.2 Cross-Linking of Polymers |
|
|
195 | (3) |
|
9.5 Antimicrobial Hydrogels with Special Additives |
|
|
198 | (2) |
|
|
200 | (9) |
|
|
201 | (1) |
|
|
201 | (8) |
|
10 Gene Therapy for the Treatment of Chronic Wounds |
|
|
209 | (26) |
|
|
|
209 | (1) |
|
10.2 Pharmacodynamics of Gene Therapy in Chronic Wounds |
|
|
210 | (2) |
|
10.2.1 Signalling Supplementation |
|
|
210 | (1) |
|
10.2.2 Pathway Inhibition |
|
|
211 | (1) |
|
10.3 Administration Routes and Methods |
|
|
212 | (1) |
|
|
212 | (1) |
|
|
212 | (1) |
|
10.3.3 Intralesional Delivery |
|
|
213 | (1) |
|
10.4 Gene Delivery Systems |
|
|
213 | (8) |
|
|
214 | (1) |
|
|
215 | (2) |
|
10.4.3 Chemical Delivery Systems |
|
|
217 | (3) |
|
10.4.4 Gene-Activated Matrices |
|
|
220 | (1) |
|
|
221 | (5) |
|
|
226 | (9) |
|
|
226 | (1) |
|
|
227 | (8) |
|
11 Honey in Wound Healing |
|
|
235 | (20) |
|
|
11.1 The History of Honey |
|
|
235 | (1) |
|
|
236 | (1) |
|
|
236 | (1) |
|
|
237 | (1) |
|
|
238 | (4) |
|
11.6 Applications and Specific Wound Types |
|
|
242 | (4) |
|
11.7 Practical Considerations |
|
|
246 | (1) |
|
11.8 Novel Concepts and Conclusions |
|
|
247 | (8) |
|
|
248 | (7) |
|
12 Regeneration Using Tissue Engineered Skin Strategies |
|
|
255 | (36) |
|
|
|
|
|
255 | (1) |
|
12.2 Skin Physiology and Wounding |
|
|
256 | (2) |
|
12.3 Skin Tissue Engineering |
|
|
258 | (1) |
|
12.4 Evolving Skin Tissue Engineering Strategies |
|
|
259 | (23) |
|
12.4.1 Balancing the Inflammatory Phase |
|
|
261 | (2) |
|
12.4.2 Enhancement of Re-Epithelialization |
|
|
263 | (6) |
|
12.4.3 Target of Dermal Matrix Synthesis and Remodeling |
|
|
269 | (1) |
|
12.4.4 Re-Establishment of the Vascular Network |
|
|
270 | (10) |
|
12.4.5 Innervation Shaping |
|
|
280 | (1) |
|
12.4.6 Appendages and Pigmentation |
|
|
281 | (1) |
|
|
282 | (9) |
|
|
283 | (8) |
|
13 Local Delivery of Growth Factors Using Wound Dressings |
|
|
291 | (24) |
|
|
|
13.1 Wound Dressings as Delivery Platforms for Growth Factors |
|
|
291 | (1) |
|
13.2 Growth Factors Involved in the Wound Healing Process |
|
|
292 | (4) |
|
13.3 Local Delivery of Growth Factors Using Wound Dressings |
|
|
296 | (3) |
|
13.4 Integration of Platelet-Rich Plasma in Wound Dressings |
|
|
299 | (1) |
|
13.5 Enhancing Local Growth Factor Expression Using Gene Therapy |
|
|
300 | (2) |
|
13.6 Wound Delivery of Growth Factors from Living Systems |
|
|
302 | (3) |
|
13.7 Regulatory Considerations |
|
|
305 | (1) |
|
13.8 Conclusions and Future Perspectives |
|
|
306 | (9) |
|
|
307 | (8) |
|
14 Electrospinning Technologies in Wound Dressing Applications |
|
|
315 | (22) |
|
|
|
|
|
|
|
315 | (1) |
|
14.2 Basic Concept and Electrospinning Set-Up |
|
|
316 | (2) |
|
14.3 Parameters Affecting the Electrospinning Process |
|
|
318 | (1) |
|
|
319 | (2) |
|
14.4.1 Electric Field Strength |
|
|
319 | (1) |
|
|
319 | (1) |
|
14.4.3 Needle-to-Collector Distance |
|
|
320 | (1) |
|
14.4.4 Collector and Needle Types |
|
|
320 | (1) |
|
|
321 | (2) |
|
14.5.1 Molecular Weight and Polymer Concentration |
|
|
321 | (1) |
|
|
322 | (1) |
|
14.5.3 Conductivity/Surface Charge Density |
|
|
322 | (1) |
|
14.5.4 Environmental Parameters |
|
|
322 | (1) |
|
14.6 Biomedical Applications of Nanofibrous Membranes |
|
|
323 | (2) |
|
14.6.1 Wound Dressings and Wound Healing |
|
|
323 | (2) |
|
14.6.2 Electrospun Dressings |
|
|
325 | (1) |
|
14.7 Chemicophysical and Biopharmaceutical Characterizations |
|
|
325 | (2) |
|
14.8 Dressing/Scaffold Parameters Affecting Cell Functions |
|
|
327 | (1) |
|
14.9 Materials for Fabricating Nanofibers |
|
|
328 | (5) |
|
|
328 | (5) |
|
|
333 | (4) |
|
|
333 | (4) |
|
15 The Place of Biomaterials in Wound Healing |
|
|
337 | (30) |
|
|
|
|
|
15.1 Introduction to Biomaterials for Wound Healing |
|
|
337 | (2) |
|
15.1.1 Definition of Biomaterials |
|
|
337 | (1) |
|
15.1.2 Functional Requirements of Wound Repair Biomaterials |
|
|
338 | (1) |
|
15.1.3 Classification of Biomaterials Commonly Used in Wound Healing |
|
|
338 | (1) |
|
15.2 Synthetic Biomaterials for Wound Healing |
|
|
339 | (4) |
|
15.2.1 Polyurethanes and their Derivatives |
|
|
340 | (1) |
|
15.2.2 Poly L-Lactic Acid |
|
|
340 | (1) |
|
15.2.3 Poly(Ethylene Glycol) |
|
|
341 | (1) |
|
|
341 | (1) |
|
15.2.5 Poly(Glycolic Acid) and Poly(Lactic-co-Glycolic Acid) |
|
|
342 | (1) |
|
15.3 Natural Biomaterials for Wound Healing |
|
|
343 | (7) |
|
15.3.1 Polysaccharide-Based Biomaterials |
|
|
343 | (5) |
|
15.3.2 Protein-Based Biomaterials |
|
|
348 | (2) |
|
15.4 Application of Biomaterials in Wound Healing |
|
|
350 | (7) |
|
15.4.1 Traditional and Impregnated Dressings |
|
|
350 | (2) |
|
|
352 | (1) |
|
|
353 | (1) |
|
|
354 | (1) |
|
15.4.5 Nanofiber-Based Dressings |
|
|
355 | (1) |
|
15.4.6 Three-Dimensional Printed Dressings |
|
|
356 | (1) |
|
15.5 New Trends in Biomaterials for Wound Healing |
|
|
357 | (1) |
|
15.5.1 Extracellular Matrix-Derived Biomaterials |
|
|
357 | (1) |
|
15.5.2 Tissue Engineered Skin Substitutes |
|
|
357 | (1) |
|
15.6 Conclusions and Future Perspectives |
|
|
358 | (9) |
|
|
359 | (8) |
|
16 Wound Dressings and Pressure Ulcers |
|
|
367 | (18) |
|
|
|
367 | (1) |
|
16.2 Introduction to Pressure Ulcers |
|
|
367 | (2) |
|
16.3 The Impact of Pressure Ulcers |
|
|
369 | (1) |
|
16.4 Managing Pressure Ulcers |
|
|
370 | (1) |
|
16.5 Wound Dressings in Pressure Ulcer Treatment |
|
|
371 | (6) |
|
16.6 Pressure Ulcer Prevention and Wound Dressings |
|
|
377 | (3) |
|
16.6.1 Pressure Ulcers at the Nose |
|
|
378 | (1) |
|
16.6.2 Pressure Ulcers at the Heel |
|
|
378 | (1) |
|
16.6.3 Pressure Ulcers at the Sacrum |
|
|
378 | (2) |
|
|
380 | (5) |
|
|
380 | (5) |
|
17 3D Printed Scaffolds for Wound Healing and Tissue Regeneration |
|
|
385 | (14) |
|
|
|
|
|
385 | (1) |
|
|
386 | (1) |
|
17.3 Laser-Based Bioprinting |
|
|
387 | (2) |
|
|
389 | (2) |
|
17.5 Extrusion-Based Printing |
|
|
391 | (2) |
|
|
393 | (2) |
|
|
395 | (4) |
|
|
395 | (4) |
Index |
|
399 | |